Treatment of High Risk Renal Tumors (COG AREN0321)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carboplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Irinotecan; Vincristine
- Indications Renal cancer; Rhabdoid tumour; Wilms' tumour
- Focus Adverse reactions; Therapeutic Use
- 21 Jul 2017 Biomarkers information updated
- 06 Jun 2013 Planned end date changed from 1 Jul 2010 to 1 Jun 2016 as reported by ClinicalTrials.gov.
- 07 Dec 2012 New source identified and integratd (Mayo Clinic).